Doximity, Inc. (DOCS)
NYSE: DOCS · IEX Real-Time Price · USD
28.22
+0.63 (2.28%)
At close: Jul 19, 2024, 4:00 PM
28.09
-0.13 (-0.46%)
After-hours: Jul 20, 2024, 12:56 PM EDT
Doximity Revenue
In the fiscal year ending March 31, 2024, Doximity had annual revenue of $475.42M with 13.45% growth. Revenue in the quarter ending March 31, 2024 was $118.06M with 6.39% year-over-year growth.
Revenue (ttm)
$475.42M
Revenue Growth
+13.45%
P/S Ratio
10.99
Revenue / Employee
$574,875
Employees
827
Market Cap
5.23B USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 475.42M | 56.37M | 13.45% |
| Mar 31, 2023 | 419.05M | 75.50M | 21.98% |
| Mar 31, 2022 | 343.55M | 136.65M | 66.05% |
| Mar 31, 2021 | 206.90M | 90.51M | 77.76% |
| Mar 31, 2020 | 116.39M | 30.69M | 35.82% |
| Mar 31, 2019 | 85.70M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Select Medical Holdings | 6.79B |
| Organon & Co. | 6.35B |
| Option Care Health | 4.43B |
| DENTSPLY SIRONA | 3.94B |
| PACS Group | 3.34B |
| R1 RCM | 2.31B |
| Merit Medical Systems | 1.28B |
| BridgeBio Pharma | 218.60M |
DOCS News
- 3 days ago - Doximity to Release Fiscal 2025 First Quarter Results on August 8, 2024 - Business Wire
- 4 weeks ago - DOXIMITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Doximity, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewsWire
- 4 weeks ago - SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Doximity, Inc. - DOCS - Accesswire
- 4 weeks ago - DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
- 5 weeks ago - FINAL DOCS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Doximity, Inc. Investors to Join the Class Action Lawsuit! - Accesswire
- 5 weeks ago - DOCS DEADLINE MONDAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important June 17 Deadline in Securities Class Action – DOCS - GlobeNewsWire
- 5 weeks ago - The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Doximity, Inc. (DOCS) - Business Wire
- 5 weeks ago - DOCS Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds Doximity, Inc. (DOCS) Investors of Filing Deadline in Class Action Lawsuit - GlobeNewsWire